Other Notices

2018-01-122018-01-11TSO (The Stationery Office), St Crispins, Duke Street, Norwich, NR3 1PD, 01603 622211, customer.services@tso.co.uk29456338015

Department of Health

THE MISUSE OF DRUGS (DESIGNATION) (AMENDMENT) ORDER (NORTHERN IRELAND) 2018

DANGEROUS DRUGS

The Department of Health has made a Statutory Rule entitled "The Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2018".

This Rule amends the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 by inserting a synthetic opioid (U-47,700), several methylphenidates related materials, a number of designer benzodiazepines and the drug known as methiopropamine or MPA into Part 1 of the Schedule to that Order; it also inserts a range of synthetic cannabinoids into Part 1 of the Schedule to that Order (which specifies the list of controlled drugs to which section 7(4) of the 1971 act applies), excluding those synthetic cannabinoids which are already specified at sub-paragraphs (h) to (s), two other compounds that have legitimate medical uses (acemetacin, atorvastatin, bazedoxifene, indomethacin, losartan, olmesartan, proglumetacin, telmisartan, viminol and zafirlukast).